The US Department of Health and Human Services (HHS) and the US Department of Defense (DOD) have jointly awarded an $11.6 million contract to Puritan Medical Products Company, Guildford, Maine, to expand domestic production capacity of Cue Sample Wands, the nasal swabs used exclusively with the covid-19 cartridge-based molecular testing system developed and manufactured by Cue Health, San Diego. The test generates results in about 20 minutes at the point-of-care (POC).
Awarded November 19, the new contract will allow Puritan Medical to expedite upgrades at its Maine facility and increase production capability of Cue’s nasal swabs to 3 million per month by March 2021. These efforts support the federal government’s procurement of 6 million Cue test kits—which include the Cue Sample Wand as well as Cue Covid-19 Test Cartridges—as part of a $481 million contract awarded to Cue October 13 to increase production to 100,000 test kits per day by March 2021. During the week of November 9, HHS began a pilot distribution of the test kits, shipping 27,000 test kits to five states.
Read more about the pilot distribution program from CLP.